Literature DB >> 17588815

Translational aspects of sphingolipid metabolism.

Youssef H Zeidan1, Yusuf A Hannun.   

Abstract

Sphingolipids, a major class of lipids in cell membranes, play diverse roles in biological processes. As bioactive and structural molecules, they have signaling activities and biophysical properties that are essential for regulating various cellular, tissue and systemic functions. Moreover, sphingolipids are receiving increasing attention as contributors to the pathogenesis of several human disorders, including, cancer, inflammation and neurological, immune and metabolic disorders. Small-molecule inhibitors and monoclonal antibodies that target sphingolipid metabolism recently enabled giant strides toward treatment of malignant and autoimmune disorders. Here, we review the emerging roles of sphingolipids in disease pathogenesis and the attendant possibilities for sphingolipid-based therapeutics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17588815     DOI: 10.1016/j.molmed.2007.06.002

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  52 in total

1.  Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response.

Authors:  D Separovic; J Bielawski; J S Pierce; S Merchant; A L Tarca; G Bhatti; B Ogretmen; M Korbelik
Journal:  Int J Oncol       Date:  2010-12-06       Impact factor: 5.650

Review 2.  Nuclear sphingolipid metabolism.

Authors:  Natasha C Lucki; Marion B Sewer
Journal:  Annu Rev Physiol       Date:  2011-09-09       Impact factor: 19.318

Review 3.  Multiple leptospiral sphingomyelinases (or are there?).

Authors:  Suneel A Narayanavari; Manjula Sritharan; David A Haake; James Matsunaga
Journal:  Microbiology       Date:  2012-03-15       Impact factor: 2.777

Review 4.  Accelerated vascular disease in systemic lupus erythematosus: role of macrophage.

Authors:  Mohammed M Al Gadban; Mohamed M Alwan; Kent J Smith; Samar M Hammad
Journal:  Clin Immunol       Date:  2015-01-28       Impact factor: 3.969

5.  C6-pyridinium ceramide sensitizes SCC17B human head and neck squamous cell carcinoma cells to photodynamic therapy.

Authors:  Nithin B Boppana; Ursula Stochaj; Mohamed Kodiha; Alicja Bielawska; Jacek Bielawski; Jason S Pierce; Mladen Korbelik; Duska Separovic
Journal:  J Photochem Photobiol B       Date:  2015-01-10       Impact factor: 6.252

Review 6.  Role of glycosphingolipids in dendritic cell-mediated HIV-1 trans-infection.

Authors:  Wendy Blay Puryear; Suryaram Gummuluru
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 7.  Cancer treatment strategies targeting sphingolipid metabolism.

Authors:  Babak Oskouian; Julie D Saba
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

8.  Incorporation and visualization of azido-functionalized N-oleoyl serinol in Jurkat cells, mouse brain astrocytes, 3T3 fibroblasts and human brain microvascular endothelial cells.

Authors:  T Walter; L Collenburg; L Japtok; B Kleuser; S Schneider-Schaulies; N Müller; J Becam; A Schubert-Unkmeir; J N Kong; E Bieberich; J Seibel
Journal:  Chem Commun (Camb)       Date:  2016-06-30       Impact factor: 6.222

Review 9.  Molecular targeting of acid ceramidase: implications to cancer therapy.

Authors:  Youssef H Zeidan; Russell W Jenkins; John B Korman; Xiang Liu; Lina M Obeid; James S Norris; Yusuf A Hannun
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

10.  Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas.

Authors:  D Separovic; J Bielawski; J S Pierce; S Merchant; A L Tarca; B Ogretmen; M Korbelik
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.